D.B. Root & Company, LLC Seagen Inc. Transaction History

D.B. Root & Company, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$117.37 - $139.17 $11,502 - $13,638	-98 Reduced 5.78%	1,598 $0
Q3 2022 Oct 26, 2022	BUY	$135.27 - $180.11 $811 - $1,080	6 Added 0.36%	1,696 $232,000
Q2 2022 Jul 21, 2022	SELL	$108.81 - $179.33 $268,216 - $442,048	-2,465 Reduced 59.33%	1,690 $299,000
Q1 2022 May 06, 2022	BUY	$119.61 - $157.85 $4,305 - $5,682	36 Added 0.87%	4,155 $598,000
Q4 2021 Feb 01, 2022	SELL	$142.57 - $190.86 $13,259 - $17,749	-93 Reduced 2.21%	4,119 $636,000

Q3 2021 Oct 22, 2021	SELL	$142.45 - $169.82 $119,800 - $142,818	-841 Reduced 16.64%	4,212 $715,000
Q2 2021 Jul 28, 2021	SELL	$135.08 - $161.1 $6,618 - $7,893	-49 Reduced 0.96%	5,053 $797,000
Q1 2021 May 04, 2021	BUY	$137.51 - $190.8 $701,576 - $973,461	5,102 New	5,102 $708,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on D.B. Root & Company, LLC with notifications on news.